ISSCR News
ISSCR Advocates for Stem Cells and Basic Research in Europe
The ISSCR met 11 April with the European Parliament’s Committee on Industry, Research and Energy to advocate for investments in basic research in the European Union’s 9th Framework Programme for Research and Innovation. ISSCR members Pete Coffey and Michele De Luca, along with ISSCR Policy Director Eric Anthony, described the need for continued investments in basic research to improve understanding of human physiology and develop new approaches to treat disease.
ISSCR Advocates for Science Investment in Letter to European Commission
In a letter to the European Commission today, the ISSCR encourages the EU to spur innovation by supporting basic research and programs that foster cooperation among fundamental research endeavors across Europe. "Sustained investments in fundamental research will stimulate innovation-led growth for years to come," according to the letter, signed by ISSCR president Hans Clevers.
'Right to Try' Legislation in U.S. House of Representatives is Narrowly Defeated; ISSCR Opposed
On 12 March, a day before a vote in the U.S. House of Representatives on 'Right to Try' legislation, the ISSCR wrote a letter to House leadership expressing opposition to the measure, which would have allowed patients access to experimental medical treatments without FDA oversight and approval. The measure was narrowly defeated 13 March.
ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products
The ISSCR commends the U.S. Food and Drug Administration (FDA) for reaffirming its regulatory authority over stem cell biologics and clarifying the criteria that determine which cell-based products fall under its oversight. These guidance documents will provide greater transparency for patients, medical professionals, and law enforcement authorities, about the legal status of stem cell treatments in the U.S.
ISSCR Comments on Horizon Europe
The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020. In its recommendations, the society prioritzied the following…
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .